A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
Rohail Memon, a second-year medical student, used his finance background to investigate the rise of private equity ownership in dermatology practice.
A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.
Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
A Northwestern Medicine study published in Nature Immunology has discovered that mitochondria control the activation of a specific protein complex linked to inflammation and the progression of chronic diseases.
Northwestern and the American Lung Association have begun a first-of-its-kind longitudinal study to track and analyze the lungs of millennials at the peak of their lung health.
A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.
Northwestern Medicine scientists identified critical regulatory processes that govern differentiation in embryonic stem cells.